SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-045727
Filing Date
2019-09-24
Accepted
2019-09-24 11:31:18
Documents
16
Period of Report
2019-09-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529886_8k.htm 8-K 20314
2 EXHIBIT 99.1 tv529886_ex99-1.htm EX-99.1 21424
3 GRAPHIC image_001.jpg GRAPHIC 68341
4 GRAPHIC image_002.jpg GRAPHIC 145859
5 GRAPHIC image_003.jpg GRAPHIC 78261
6 GRAPHIC image_004.jpg GRAPHIC 106256
7 GRAPHIC image_005.jpg GRAPHIC 82805
8 GRAPHIC image_006.jpg GRAPHIC 75131
9 GRAPHIC image_007.jpg GRAPHIC 81591
10 GRAPHIC image_008.jpg GRAPHIC 69381
11 GRAPHIC image_009.jpg GRAPHIC 88587
12 GRAPHIC image_010.jpg GRAPHIC 84355
13 GRAPHIC image_011.jpg GRAPHIC 52330
14 GRAPHIC image_012.jpg GRAPHIC 68893
15 GRAPHIC image_013.jpg GRAPHIC 82875
16 GRAPHIC image_014.jpg GRAPHIC 61260
  Complete submission text file 0001144204-19-045727.txt   1623225
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 191109678
SIC: 2834 Pharmaceutical Preparations